Germline BRCA1and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Peter A. Fasching, Chunling Hu, Steven Hart, Andreas D. Hartkopf, Florin A Taran, Wolfgang Janni, Hans Tesch, Lothar Haeberle, Johannes Ettl, Friedrich Overkamp, Michael P Lux, Diana Lüftner, Markus Wallwiener, Volkmar Mueller, Hans-Christian Kolberg, Tanja N. Fehm, Diethelm Wallwiener, Sara Brucker, Andreas Schneeweiss, Fergus Couch, PRAEGNANT Study Group
Institutions: Universitätsklinikum Erlangen, Mayo Clinic, University of Tübingen, Universität Ulm, Friedrich-Alexander-Universität Erlangen-Nürnberg, Charité – Universitätsmedizin Berlin, Heidelberg University, University Medical Center Hamburg-Eppendorf, Marienhospital Bottrop, Heinrich Heine University Düsseldorf, Universitätsklinikum Tübingen, German Cancer Research Center, University Hospital Heidelberg, National Center for Tumor Diseases
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2947322834